良性攝護腺肥大經尿道手術後發生暫時性急迫性尿失禁的危險因子探討

鄧子麒、陳祈翰、林彥均、邵翊紘、謝明里

林口長庚醫院 外科部 泌尿科

Risk factors for transient urge urinary incontinence after transurethral procedures in the treatment of benign prostatic hyperplasia

Tzu-Chi Teng; Chi-Han, Chen; Yen-Chun, Lin; I-Hung, Shao; Ming-Li, Hsieh

Divisions of Urology, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan

Purpose:

The aim of this study was to find the potential risk factors of transient urge urinary incontinence after transurethral procedures in the treatment of benign prostatic hyperplasia.

Materials and Methods:

This was a retrospective, single-center study that included 370 patients received of transurethral procedure in the treatment of benign prostatic hyperplasia (BPH) from May 2016 to December 2016. Patients with urinary incontinence, genitourinary cancer, or previous transurethral procedure were excluded. Comprehensive data was collected before and after transurethral procedures from medical records. Statistical analysis was used to evaluate associations between parameters and postoperative urge incontinence. All patients followed up at our OPD regularly after operation. The end point was urge urinary incontinence (UUI) diagnosed within one month after transurethral procedure for BPH.

Results:

The incidence of the patient with postoperative incontinence was 13.1% which divided into UUI 11%, SUI 1.2% and MUI 0.9%. IPSS (26.0 [22.0, 29.0] versus 24.0 [21.0, 27.0], p=0.019), IPSS storage subscore (IPSS-S) (11.0 [10.0, 13.0] versus 10.0 [8.0, 12.0], p=0.04), and hospital day (3.0 [3.0, 5.0] versus 3.0 [3.0, 4.0], p=0.016) was significant predictor for transient UUI within one month after transurethral procedure for BPH.

Conclusion:

In our cohort study, we found IPSS and IPSS-S as preoperative predictor and hospital day as postoperative predictor for transient urge incontinence within one month after transurethral procedure for BPH.